or
forgot password

    • cancer clinical trials in arkansas

    • Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Brain Tumor, Central Nervous System Tumor
    S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lung Cancer
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Arkansas Oncology Associates, PA
    Little Rock, Arkansas 72207
    Non-Small Cell Lung Cancer
    Non-small Cell Lung Cancer Study US75 (Z-PACT)
    NEA Clinic

    Trial Locations
    NEA Clinic
    Highlands Oncology Group
    Non Small Cell Lung Carcinoma
    STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
    NEA Clinic
    Jonesboro, Arkansas 72401
    Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung Cancer
    Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Multiple Myeloma
    ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer
    Research Site
    Bentonville, Arkansas
    Colorectal Cancer, Metastases
    Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis
    Bressnick Gibson Parker Dinehart Sangster Dermatology, P.A.
    Little Rock, Arkansas 72205
    Psoriatic Arthritis
    Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Sarcoma
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Little Rock Hematology Oncology Associates
    Little Rock, Arkansas 72205
    Lung Cancer, Non-small-cell Lung Carcinoma
    Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Multiple Myeloma
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Esophageal Cancer
    S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Sarcoma
    A Study of E7389 in Advanced/Metastatic Breast Cancer Patients

    Little Rock, Arkansas 72205-7199
    Breast Neoplasms
    Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Non-small Cell Lung Cancer Registry
    Hembree Cancer Center-St. Edward Mercy Medical Center
    Fort Smith, Arkansas 72903
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Brain and Central Nervous System Tumors
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    North Little Rock, Arkansas 72117
    Colorectal Neoplasms
    Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
    GSK Investigational Site
    Little Rock, Arkansas 72205
    Constipation, Bowel Dysfunction
    SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
    GSK Investigational Site
    Little Rock, Arkansas 72205
    Thrombocytopenia, Thrombocytopaenia
    TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Arkansas Oncology Associates
    Little Rock Hematology Oncology
    Ovarian Neoplasms
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Myeloma Institute For Research Therapy
    Little Rock, Arkansas 72205
    Multiple Myeloma
    S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Melanoma (Skin)
    OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
    Saint Joseph's Mercy Cancer Center

    Trial Locations
    Saint Joseph's Mercy Cancer Center
    Hot Spring Pain Clinic
    Arkansas Cancer Institute
    Pain, Cancer
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Breast Cancer
    Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Brain and Central Nervous System Tumors
    DT PACE, Tandem Autologous Transplant, Maintenance Therapy for Waldenstrom's Macroglobulinemia Patients
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Waldenstrom Macroglobulinemia
    S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Esophageal Cancer
    S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma, Plasmacytoma
    Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer
    University of Arkansas, Arkansas Cancer Research Center
    Little Rock, Arkansas 72205
    Lung Cancer, Non Small Cell Lung Carcinoma
    Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer
    Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
    Ft. Smith, Arkansas 72903
    Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lung Cancer
    UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy
    Multiple Myeloma
    Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer
    Genesis Cancer Center
    Hot Springs, Arkansas 71913
    Small Cell Lung Cancer
    Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
    Children's Clinic of Jonesboro, PA
    Jonesboro, Arkansas 72401
    Warts
    Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)
    Pfizer Investigational Site
    North Little Rock, Arkansas 72117
    Lymphoma
    S0515 Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
    Ben E. Owens Cancer Treatment Center at St. Bernard's Medical Center

    Trial Locations
    Ben E. Owens Cancer Treatment Center at St. Bernard's Medical Center
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Lymphoma
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    Arkansas Urology
    Little Rock, Arkansas 72211
    Prostate Cancer, Osteoporosis, Fractures
    Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients
    St. Edward Mercy Medical Center
    Fort Smith, Arkansas 72917
    Prostate Cancer
    Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma
    Arkansas Children's Hospital
    Little Rock, Arkansas 72202-3591
    Osteosarcoma
    Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma
    A Phase III Trial For Patients With Metastatic Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician.

    Trial Locations
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician.
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Breast Cancer, Breast Neoplasms, Cancer of the Breast